Compounds > ethoxyresorufin
Page last updated: 2024-10-26

ethoxyresorufin and Obesity

ethoxyresorufin has been researched along with Obesity in 1 studies

ethoxyresorufin: structure

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DuBois, BN1
O'Tierney-Ginn, P1
Pearson, J1
Friedman, JE1
Thornburg, K1
Cherala, G1

Other Studies

1 other study available for ethoxyresorufin and Obesity

ArticleYear
Maternal obesity alters feto-placental cytochrome P4501A1 activity.
    Placenta, 2012, Volume: 33, Issue:12

    Topics: Animals; Body Mass Index; Cytochrome P-450 CYP1A1; Cytosol; Diet, High-Fat; Down-Regulation; Female;

2012